OncoQuest

OncoQuest Inc. is a clinical-stage biotechnology company and a subsidiary of Quest Pharmatech (QPT: TSXV), headquartered in Canada. The company focuses on the commercialization of a portfolio of immunomodulatory antibodies for cancer treatment. These antibodies target various oncogenic proteins, including CA-125, MUC 1, PSA, and Her2/neu.